Catheter-based alternative treatment for early-stage lung cancer with a high-risk for morbidity | Zendy

Ze-Rui Zhao | Zendy; Rainbow W. H. Lau | Zendy; Calvin S.H. Ng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Catheter-based alternative treatment for early-stage lung cancer with a high-risk for morbidity

Author(s) -

Ze-Rui Zhao,

Rainbow W. H. Lau,

Calvin S.H. Ng

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.03.151

Subject(s) - medicine , cryoablation , microwave ablation , lung cancer , stage (stratigraphy) , radiofrequency ablation , surgery , ablation , intensive care medicine , oncology , paleontology , biology

The mainstream treatment modality for early stage non-small cell lung cancer (NSCLC) is surgery; however, many patients are deemed inoperable and warrant alternative therapeutic options. Several minimally invasive catheter-based therapies are emerging as viable alternatives. In this review, we evaluate the outcomes from radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation (CRA) and photodynamic therapy (PDT) for early-stage lung cancer. Novel technical developments have allowed for endobronchial thermal ablation to be conducted in a hybrid theatre setting, which may optimize treatment outcomes and minimise treatment-related complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research